19 October 2026
strategyland.uk
Man Group PLC (EMG)
Rank #32 of 280 - Financials - UK Equities
Man Group PLC
Factor Analysis Summary
Editorial assessment generated from Man Group PLC's live factor scores and sector positioning.
Based on Strategyland's proprietary 7-factor analysis, Man Group PLC (EMG.L) currently holds an overall rank of #32 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.
Key strengths include liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit; technical (RSI 47.6), where it demonstrates generally favourable technical indicators with price holding above key moving averages; and profitability (ROE 10.8%, net margin 18.7%), where it demonstrates healthy profit margins and returns that exceed the median FTSE 100 company.
Areas requiring attention include solvency (debt/equity 0.2), where balance sheet metrics are unexceptional and offer limited downside protection, as well as valuation (P/E 16.0, dividend yield 4.4%), where valuation offers limited margin of safety at current price levels.
Within the Financials sector, Man Group PLC sits at composite rank #32, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.
Ranking in the top quartile overall, Man Group PLC offers a favourable balance of fundamentals, though investors should weigh its liquidity advantage against solvency — its relatively weakest factor.
Strongest Factors
- Liquidity — Rank 4/280 (top quartile)
- Technical — Rank 72/280 (above average)
- Profitability — Rank 78/280 (above average)
Weakest Factors
- Solvency — Rank 164/280 (middle of the pack)
- Valuation — Rank 155/280 (middle of the pack)
Score Analysis
Man Group PLC is ranked #32 out of 280 UK stocks. Lower factor scores indicate better performance in that category.
Factor Breakdown
1. Liquidity
Score: 4/280How liquid is EMG and can it meet its short-term obligations?
Key Liquidity Metrics
Overall Liquidity Rank
2. Valuation
Score: 155/280Is EMG undervalued compared to its peers and fair value metrics?
Key Valuation Metrics
Dividend
EMG pays a dividend yield of 4.42%.
Dividend Per Share Forecast
3. Profitability
Score: 78/280How profitable is EMG relative to its peers?
EPS Growth
4. Solvency
Score: 164/280How strong is EMG's balance sheet and financial position?
Key Solvency Metrics
Altman Z-Score
5. Asset Efficiency
Score: 153/280How efficiently does EMG deploy its assets and intellectual capital?
Overall Asset Efficiency Rank
6. Market Trading
Score: 145/280How liquid and actively traded is EMG?
Trading Volume
7. Technical
Score: 72/280What do the technical indicators say about EMG?
RSI (14 Day)
Moving Averages
Risk Metrics
Peer Comparison
How does EMG compare to other Financials stocks?
Overall Rank Comparison
Factor Score Comparison
Similar Stocks
Other top-ranked stocks in the Financials sector
LiveCatch Healthcare Events Before the Market Moves
SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.
Methodology Note
The analysis presented for Man Group PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.
Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.
This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.
© 2026 Strategyland by Khurram. All rights reserved.
